Carola Berking is an expert in Dermatology at Universitätsklinikum Erlangen (Germany). As of October 2026, ScienceLeadR ranks Carola Berking in the top 1% of experts worldwide for Keratosis, Skin Neoplasms and Melanoma. Carola Berking has authored 581 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,840 (community average: 125). How the SLR is computed.

LeadR Profile

Carola Berking Universitätsklinikum Erlangen Germany
1 840 ScienceLeadR Reputation 1840
Network Map

Dermatology

Subspecialties: Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026

Source: PubMed

University of Erlangen-Nuremberg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 581

Citations

Citations: 36 288 1st author: 25 Last author: 131 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
How much sweating is enough? Predicting thermoregulatory capacity in patients with ectodermal dysplasia based on a minimal pilocarpine-induced sweat volume.
PMID 42683232 — sweating, pilocarpine, iontophoresis, body temperature regulation, signs and symptoms, ectodermal dysplasia 1, anhidrotic, mutation, temperature, ectodermal dysplasia
Front Pediatr20260
AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma.
PMID 42616540 — skin, cells, feasibility studies, tomography, skin diseases, tomography, optical coherence, diagnosis, artificial intelligence, wounds and injuries, carcinoma, basal cell
JAMA Dermatol20260
Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study.
PMID 42564088 — melanoma, multiple chronic conditions, immune system diseases, therapeutics
Front Immunol20260
Deep Phenotyping and Molecular Elucidation of a New Syndrome: Ectodermal Dysplasia Caused by IRF6 Variants.
PMID 42487474 — skin, natal teeth, genes, tooth, skin diseases, hearing, diagnosis, hearing loss, ectoderm, ectodermal dysplasia
Exp Dermatol20261
Organ Involvement and Treatment Response across Cutaneous Sarcoidosis Subtypes.
PMID 42328997 — sexually transmitted diseases, sarcoidosis, diagnosis, therapeutics, dermatology
Acta Derm Venereol20261

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 7
Phase 3 6
N/A 2
Phase 1 2
Phase 1/Phase 2 1

By status:

Completed 16
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 18

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 0
multicentric5to9 1
multicentricup10 11

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
BCC One Stop Study
NCT07482956 — skin, cells, margins of excision, tomography, surgical procedures, operative, neoplasms, tomography, optical coherence, mohs surgery, carcinoma, basal cell, prospective studies, skin neoplasms, carcinoma
N/ANot yet recruiting2026

LeadR Networks

Main global connection map